Cargando…
miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation
Sorafenib is a classical targeted drug for the treatment of advanced hepatocellular carcinoma (HCC), but intrinsic resistance severely limited its therapeutic effects. In the present study, we aimed to identify crucial genes in HCC cells that affect sorafenib resistance by a CRISPR/Cas9 genome-scale...
Autores principales: | Li, Li, Yu, Shijun, Chen, Jingde, Quan, Ming, Gao, Yong, Li, Yandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237098/ https://www.ncbi.nlm.nih.gov/pubmed/35760798 http://dx.doi.org/10.1038/s41420-022-01094-2 |
Ejemplares similares
-
miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway
por: Alqurashi, Naif, et al.
Publicado: (2019) -
Repression of human activation induced cytidine deaminase by miR-93 and miR-155
por: Borchert, Glen M, et al.
Publicado: (2011) -
Echinacoside Suppresses the Progression of Breast Cancer by
Downregulating the Expression of miR-4306 and miR-4508
por: Bian, Peng, et al.
Publicado: (2021) -
Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012) -
Compound 331 selectively induces glioma cell death by upregulating miR-494 and downregulating CDC20
por: Zhang, Lei, et al.
Publicado: (2015)